FDA Investigator Nicholas J Lahey
Nicholas J Lahey has inspections in 1 countries as of 30 Aug 2023. Nicholas J Lahey has collaborated with a combined 2016 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
107
Last Inspection Date:
30 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Albert C Cheng,
Alexandra B Pitkin,
Alfredo Iniguez Garcia,
Ali Hernandez,
Alice A Blair,
Aliza Chalapong Asawesna,
Ana Djurdjevic,
Angela Shepas,
Anthony E Guzman,
Ashley J Allen Gaines,
Brandon R Boone,
Burnsb,
Bush,
Carr Sharpe,
Cathryn M Groehnert,
Chelsea N Sealey,
Christopher J Stannard,
Claire C Tipton,
Cristina E Mosquera,
Cristina Resendiz Navarrete,
Danielle M Didonna,
Darrin E Davis,
Davis,
Debbie K Giang,
Deborah W Hsu,
Debra J Fracassa,
Dejon N Harris,
Dennis N Hoang,
Desiree C Iya,
Edna J Hidalgo,
Eileen T Dupont,
Elizabeth M Dahl,
Elizabeth Q Maccorkell,
Ellen N Stewart,
Emal Wahab,
Erik D Sandvig,
Erik M Slama,
Fe Q Reyes,
Francisco,
Garciam,
Gene Matienzo,
Gonzalo Castillo,
Gordon Chu,
Grace P Santos,
Guillermo,
Hai T Truong,
Henry E Carrillo,
Herminio C Francisco,
Hoover,
Jake T Lane,
James A Barreto,
James A Lentz,
Jeannie Pradyanata,
Jeffrey W Shrifter, DPM,
Jennifer P Le,
Jessica J Lee,
Jessica L Andrade,
Jhakeim D Seaberry,
Jinnie Kokiatkulkij,
Joey V Quitania,
John A Liu,
John R Myung,
Joseph C Francisco,
Joseph H Lam,
Judy C Nepsa,
Kai Wang,
Katherine P Tran,
Kelvin X Sanders,
Kevin Lee,
Khang K Pham,
Kimberly M Lichter,
Lilly O Barton,
Lin Liu,
Ling Yul Liu,
Lorraine N Williams,
Loydis Laureano,
Marco A Solorio,
Mark C Saale,
Mark Gray,
Mark I Nakano,
Martina Santillanes,
Matthew C Kristof,
Michael D Garcia,
Michael J Chan,
Michael P Dimaano,
Nancy E Byerly,
Natalie J Ayoub,
Natalie J Reese,
Naveen B Walker,
Ngoc T Le,
Nianna C Burns,
Nicolas C Tolosa,
Nympha V Florendo,
Ounchith J Phabmixay,
Pamela Y Lee,
Patrick R Dimapindan,
Phillip L Toy,
Richard W Tubb,
Robert C Hoover,
Rocio Guzman Velazquez,
Ronald P Boyce,
Sabrina J Dethloff,
Sandersk,
Sarah R Barker,
Sean D Duke,
Sean P Desbrow,
Steve P Yost,
Sundy V Sedwick,
Sundy Ven,
Susanna N Choi,
Sylvia A Thomas,
Tamara L Alexander,
Tammy Vasquez Hancock,
Terrance P Nguyen,
Terry L Boles,
Thao T Kwan,
Tony J Wu,
Tracy M Portelli,
Trushani T Desai,
Victoria C Yang,
Wayne L Jefferson,
Wr Bowman,
Yvonne T Lacour
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more